Filing Details
- Accession Number:
- 0001156039-24-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-23 17:02:46
- Reporting Period:
- 2024-07-22
- Accepted Time:
- 2024-07-23 17:02:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1156039 | Elevance Health Inc. | ELV | Hospital & Medical Service Plans (6324) | 352145715 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1287920 | Gail Boudreaux | 220 Virginia Avenue Indianapolis IN 46204 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-07-22 | 1,100 | $498.50 | 159,609 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-22 | 20,779 | $500.36 | 138,830 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-22 | 6,621 | $501.40 | 132,209 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-22 | 2,250 | $502.23 | 129,959 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-22 | 1,000 | $503.67 | 128,959 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-07-22 | 2,250 | $504.27 | 126,709 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 60 | Indirect | Shares Held in Spouse's Revocable Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 19, 2024.
- This transaction was executed in multiple trades at prices ranging from $499.82 to $500.81. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $500.83 to $501.79. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $501.96 to $502.65. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $503.05 to $503.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $504.1 to $504.99. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
